Fruitful investment for Fertilty Focus
Fertility Focus, based in Warwick, has received £775,000-worth of funding. The investment was made by several parties and includes £375,000 of backing from the Exceed Midlands Advantage Fund.
The company is developing products which aim to increase pregnancy rates in infertile couples by up to 50 per cent.
Along with the investment from the Exceed fund, which is managed by Midven, the company received a £250,000 boost from Norgenix, a US-based distributor of women’s health products. Further backing came from three individual investors through Envestors.
Robert Milnes, chief executive of Fertility Focus, said: “We are delighted to receive the backing of Midven in our efforts to improve the diagnosis and treatment of infertility. We have exciting plans for developing the business and look forward to working with Midven as we grow.”
Fertility Focus was formed in 2005 to licence intellectual property for the Fertility Monitor from Bristol University. Since its inception, the company has developed two products to assist with infertility.
